Back to 
Moore Capital Management, LP
Moore Capital Management, LP
TXG
6 quarters
Position history for Moore Capital Management, LP's holdings in 10x Genomics, Inc.
No. Moore Capital Management exited its TXG (10x Genomics) position in Q4 2025. Its Q3 2025 13F listed 54,216 shares worth $633,785. Moore Capital Management first reported TXG in Q1 2023 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$2.8M
Total Shares Change
-50,000
Quarter-by-Quarter History
Other major holders of TXG: FMR LLC